广州高澜节能技术股份有限公司 2025 年第三季度报告 广州高澜节能技术股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 1 广州高澜节能技术股份有限公司 2025 年第三季度报告 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）声明：保证 季度报告中财务信息的真实、准确、完整。 证券代码：300499 证券简称：高澜股份 公告编号：2025-041 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 170,030,185.72 | 115.10 ...

Financial Performance - The company's revenue for Q3 2025 was ¥208,773,789.27, representing an increase of 8.19% compared to the same period last year, and a year-to-date revenue of ¥591,566,032.66, up 19.32%[5] - The net profit attributable to shareholders for Q3 2025 was -¥23,699,266.77, a decrease of 39.51% year-on-year, with a year-to-date net profit of -¥59,466,792.28, reflecting an increase in losses of 8.24%[5] - The basic earnings per share for Q3 2025 was -¥0.11, down 37.50% compared to the same period last year, while the diluted earnings per share was -¥0.10, a decrease of 42.86%[5] - Total operating revenue for the current period reached ¥591,566,032.66, an increase of 19.3% compared to ¥495,770,101.99 in the previous period[21] - Net loss for the current period was ¥59,466,792.28, slightly improved from a net loss of ¥64,806,517.98 in the previous period[22] - Basic earnings per share for the current period was -¥0.27, compared to -¥0.30 in the previous period[22] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥2,468,233,754.87, a decrease of 6.43% from the end of the previous year[5] - Total assets decreased to ¥2,468,233,754.87 from ¥2,637,844,177.86, reflecting a decline of 6.4%[19] - Total liabilities decreased to ¥899,275,574.76 from ¥1,009,233,425.71, a reduction of 10.9%[19] - Total current assets decreased from ¥1,459,025,411.18 to ¥1,266,051,065.22, a reduction of about 13.2%[17] - Long-term receivables decreased from ¥6,623,963.79 to ¥3,842,028.41, a decline of about 42.4%[17] - Non-current assets totaled ¥1,202,182,689.65, slightly up from ¥1,178,818,766.68, indicating a growth of 2.0%[19] Cash Flow - The cash flow from operating activities for Q3 2025 was -¥103,078,002.12, a significant decline of 222.46% compared to the previous year[9] - Operating cash flow for the current period was -¥103,078,002.12, a decrease from ¥84,176,059.20 in the previous period[23] - Total cash outflow from operating activities was ¥555,339,407.97, compared to ¥417,234,241.58 in the prior period[23] - Cash inflow from investment activities increased to ¥1,556,956,815.22, compared to ¥1,159,692,002.15 in the prior period[23] - Net cash flow from investment activities was ¥149,153,615.83, up from ¥63,563,383.37 year-over-year[23] - Cash inflow from financing activities totaled ¥573,515,475.65, compared to ¥534,380,875.67 in the previous period[24] - Net cash flow from financing activities improved to -¥37,693,720.76 from -¥224,624,005.58 year-over-year[24] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 47,329[11] - The largest shareholder, Jijing (Hong Kong) Limited, holds 31.65% of shares, totaling 68,910,043 shares[11] - The total number of restricted shares at the end of the period is 605,923 shares, with 32,907 shares newly restricted[14] - The company has no preferred shareholders or related changes in preferred stock ownership[12] - There are no significant changes in the top 10 shareholders or their shareholding status due to securities lending[12] Operating Costs and Expenses - The company experienced a 32.25% increase in operating costs, totaling ¥538,165,085.47, due to higher sales revenue[9] - Total operating costs increased to ¥652,890,884.22, up 14.7% from ¥569,333,866.84 in the previous period[21] - Research and development expenses for Q3 2025 amounted to ¥70,614,368.20, a decrease of 36.69% year-on-year, primarily due to costs related to products entering mass production being directly included in operating costs[8] - Research and development expenses were ¥70,614,368.20, down 36.7% from ¥111,531,705.77 in the previous period[21] - The company reported a significant decrease in other income, which fell by 79.36% to ¥6,349,045.12, primarily due to reduced government subsidies received[9] Audit and Compliance - The company did not undergo an audit for the third quarter financial report[25]

Financial Performance - The company's revenue for Q3 2025 reached ¥2,002,513,077.85, representing a year-on-year increase of 10.51%[5] - Net profit attributable to shareholders was ¥192,624,580.35, up 14.35% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥177,968,074.77, reflecting a 17.56% increase year-on-year[5] - Total operating revenue for the third quarter reached ¥5,164,644,598.68, an increase of 11.5% compared to ¥4,630,797,259.92 in the previous year[23] - Operating costs amounted to ¥4,742,113,069.82, up from ¥4,273,366,339.58, reflecting a year-over-year increase of 11%[23] - Net profit for the period was ¥450,225,808.76, representing a 14.9% increase from ¥391,694,272.53 in the same quarter last year[24] - The company reported a basic earnings per share of ¥0.3692, compared to ¥0.3141 in the previous year, marking a 17.5% increase[24] Asset Management - The total assets at the end of the reporting period amounted to ¥13,265,498,006.66, an increase of 5.03% from the end of the previous year[5] - Total current assets amount to ¥11,330,317,042.95, an increase from ¥10,699,333,455.80 at the beginning of the period, representing a growth of approximately 5.9%[20] - The company's total liabilities rose to ¥7,323,422,447.58 from ¥7,022,808,534.22, indicating an increase in financial obligations[22] - The company’s total non-current assets amounted to ¥1,935,180,963.71, slightly up from ¥1,930,469,650.97, indicating stability in long-term asset management[21] Cash Flow - Cash flow from operating activities showed a net outflow of ¥354,764,561.56, a significant decrease of 407.96% compared to the previous year[5] - Cash flow from operating activities was ¥5,496,375,190.82, slightly up from ¥5,329,540,178.42 in the previous year, showing stable cash generation[26] - Total cash inflow from operating activities amounted to 5,684,362,593.72, compared to 5,507,940,523.02 last year, reflecting an increase of approximately 3.2%[27] - Cash outflow from operating activities totaled 6,039,127,155.28, up from 5,392,741,261.58, indicating a rise of about 12%[27] - The ending cash and cash equivalents balance was 3,370,077,714.91, compared to 3,139,149,459.86 at the end of the previous year, showing an increase of approximately 7.4%[28] Shareholder Information - Total number of common shareholders at the end of the reporting period is 68,837[17] - The largest shareholder, Dongfang Electronics Group Co., Ltd., holds 27.58% of shares, totaling 369,774,238 shares[17] - The top 10 shareholders do not participate in margin financing or securities lending activities[18] - The company has no preferred shareholders or related changes in the reporting period[18] - The total number of shareholders with voting rights restored for preferred shares is 0[17] Investment and Development - Research and development expenses increased to ¥475,673,125.53, up from ¥428,070,344.97, indicating a focus on innovation and product development[23] - Long-term equity investments were reported at ¥111,386,582.98, up from ¥96,615,796.95, suggesting strategic investments in growth opportunities[21] - The company’s subsidiary, Yantai Haiyi Software Co., Ltd., is in the process of publicly issuing stocks and preparing for listing on the National SME Share Transfer System[18] Asset Changes - The balance of contract assets decreased by ¥112,305,528.51, a reduction of 39.93% due to the expiration of certain contract assets[9] - The balance of construction in progress increased by ¥19,559,537.28, a substantial rise of 882.83% due to new construction projects[10] - The balance of other current assets increased by ¥120,829,739.75, reflecting a growth of 65.52% primarily due to increased prepaid taxes[9] - The company reported a decrease in asset impairment losses of ¥653,381.56, a reduction of 62.25% due to lower provisions for bad debts on contract assets[13]

Financial Performance - The company's operating revenue for Q3 2025 was CNY 329,438,101.91, representing a year-on-year increase of 10.27%[4] - The total profit for the period reached CNY 35,312,818.63, marking a significant increase of 29.32% compared to the same period last year[4] - The net profit attributable to shareholders was CNY 30,713,472.88, which is a 4.60% increase year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 27,509,635.48, showing a decrease of 6.52% compared to the previous year[4] - Total operating revenue for the first three quarters of 2025 reached ¥909,880,380.47, an increase of 10.9% compared to ¥820,283,011.52 in the same period of 2024[17] - Net profit for the first three quarters of 2025 was ¥78,783,011.66, compared to ¥72,071,854.45 in 2024, representing an increase of 9.9%[19] - Operating profit for the first three quarters of 2025 was ¥91,625,458.95, an increase from ¥80,859,972.53 in the same period of 2024, marking a growth of 13.7%[18] Cash Flow - The cash flow from operating activities for the year-to-date period was CNY 148,759,843.04, reflecting a substantial increase of 159.21%[8] - Cash flow from operating activities for the first three quarters of 2025 was ¥604,418,664.43, compared to ¥541,870,246.48 in 2024, indicating an increase of 11.5%[21] - Net cash flow from operating activities reached $148,759,843.04, significantly up from $57,389,010.63, indicating a year-over-year increase of over 159%[22] - Cash inflow from investment activities was $1,103,222,053.87, compared to $533,475,463.14, marking an increase of approximately 106%[22] - Cash inflow from financing activities amounted to $218,760,024.25, up from $100,000,000.00, representing a 118% increase[23] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,622,860,653.74, a slight decrease of 0.10% from the previous year-end[5] - Current assets totaled RMB 1,150,285,012.10, a minor decrease from RMB 1,155,379,690.23 in the previous year[13] - The total liabilities decreased to ¥684,354,766.79 in 2025 from ¥734,567,723.39 in 2024, a reduction of approximately 6.8%[15] - The total liabilities and equity amounted to ¥2,622,860,653.74 in 2025, slightly down from ¥2,625,377,837.87 in 2024[15] Shareholder Information - The equity attributable to shareholders increased to CNY 1,938,030,070.70, representing a growth of 2.39% compared to the previous year-end[5] - Total equity attributable to shareholders increased to ¥1,938,030,070.70 in 2025 from ¥1,892,728,061.37 in 2024, reflecting a growth of 2.4%[15] - The basic earnings per share for the period was CNY 0.0796, which is a 4.60% increase year-on-year[4] - The basic earnings per share for the first three quarters of 2025 was ¥0.2043, a decrease from ¥0.2237 in 2024, reflecting a decline of 8.5%[19] Operational Metrics - Research and development expenses for the first three quarters of 2025 were ¥50,561,510.10, up from ¥40,533,340.06 in 2024, showing a rise of 24.8%[18] - The company reported non-recurring gains totaling CNY 3,203,837.40 for the current period[7] - The company plans to implement new accounting standards starting in 2025, which may impact future financial reporting[24] Future Outlook - Future outlook includes potential market expansion and new product development strategies[12]

Financial Performance - Q3 2025 revenue reached ¥2,722,819,880.54, an increase of 5.68% year-over-year[4] - Net profit attributable to shareholders was ¥84,454,457.55, a significant increase of 169.63% compared to the same period last year[4] - The net profit after deducting non-recurring gains and losses was ¥83,798,385.80, up 253.91% year-over-year[4] - Total revenue for the current period reached ¥8,703,973,533.69, an increase of 5.65% compared to ¥8,237,562,153.58 in the previous period[26] - Net profit for the current period was ¥224,279,785.80, a decrease of 25.7% from ¥301,992,109.07 in the previous period[27] - The net profit attributable to the parent company shareholders was approximately ¥103.58 million, a decrease from ¥218.45 million in the previous period, reflecting a decline of about 52.6%[28] - The total comprehensive income amounted to ¥224.00 million, down from ¥301.70 million, indicating a decrease of approximately 25.8%[28] - The basic and diluted earnings per share were both ¥0.0852, compared to ¥0.1798 in the previous period, representing a decline of about 52.6%[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥27,522,096,860.05, reflecting a 1.63% increase from the end of the previous year[4] - Current assets totaled ¥6,913,002,842.25, up from ¥6,708,585,319.87, representing a rise of 3.05%[23] - Total liabilities increased to ¥8,715,284,976.30 from ¥8,346,799,691.26, marking a growth of 4.42%[24] - The company's total equity increased to ¥18,806,811,883.75 from ¥18,732,720,423.86, reflecting a growth of 0.4%[24] Cash Flow - Cash flow from operating activities for the first nine months was ¥932,078,152.68, down 19.72% compared to the previous year[4] - Cash flow from operating activities generated a net amount of ¥932.08 million, down from ¥1.16 billion, a decrease of approximately 19.7%[30] - Cash inflow from investment activities was ¥8.33 billion, significantly higher than ¥4.41 billion in the previous period, marking an increase of approximately 88.5%[30] - The net cash flow from financing activities was negative at ¥51.51 million, compared to a positive cash flow of ¥398.31 million in the previous period[30] - The ending balance of cash and cash equivalents was ¥2.01 billion, an increase from ¥1.95 billion in the previous period[31] - The company's cash and cash equivalents increased by ¥303,744,211.67, a 198.52% improvement compared to the previous year[11] - The company's cash and cash equivalents at the end of the period were ¥2,096,006,541.45, compared to ¥1,790,590,187.68 at the beginning of the period, an increase of 17.03%[22] Investments and Projects - The company plans to invest 350 million RMB in the construction of multifunctional workshops and raw material drug workshops in Jiangxi Yingtan National High-tech Zone[18] - The POE project in Qingdao has initiated basic design work and is currently in the procurement phase for long-cycle equipment[17] - The high-performance liquid crystal materials industry upgrade project has completed feasibility studies and is now in the construction phase[20] - The company has received a refund of 9 million RMB related to the land use rights recovery contract[19] - The company is in discussions with Wansheng Bio regarding a debt repayment plan, with a total claim of approximately 133.18 million RMB[20] - The company is preparing for the IPO of its subsidiary Chengzhi Yonghua, focusing on regulatory compliance and communication with authorities[17] - The company has initiated the construction of a health insurance company, with a planned registered capital of 1 billion RMB, but progress is currently stalled[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 41,482[13] - The largest shareholder, Chengzhi Kairun Holdings Co., Ltd., holds 30.83% of shares, totaling 374,650,564 shares[13] - Tianfu Qingyuan Holdings Co., Ltd. holds 15.77% of shares, totaling 191,677,639 shares, with 31,057,699 shares frozen[13] Other Financial Metrics - The company reported a 34.49% decrease in total profit for the first nine months of 2025, amounting to ¥276,937,812.54[10] - The company's long-term borrowings rose by 50.14% to ¥1,996,533,100.59, attributed to loan structure optimization[8] - Research and development expenses for the current period were ¥224,637,331.82, slightly up from ¥214,475,931.87 in the previous period[27] - The company received tax refunds amounting to ¥52.96 million, compared to ¥12.68 million in the previous period, indicating a significant increase of approximately 317.5%[30] - The total cash outflow from investment activities was ¥8.92 billion, up from ¥6.30 billion, reflecting an increase of approximately 41.7%[30] - The company reported a decrease in other comprehensive income attributable to the parent company, with a net amount of -¥279,666.41, compared to -¥296,137.18 in the previous period[28]

Financial Performance - The company's operating revenue for Q3 2025 was ¥190,370,648.06, a decrease of 38.86% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥22,288,544.63, representing a decline of 300.76% year-on-year[5]. - The net cash flow from operating activities was -¥130,024,776.79, a decrease of 207.78% compared to the previous year[11]. - Total operating revenue decreased to ¥683,377,689.36 from ¥738,616,803.96, representing a decline of approximately 7.5%[22]. - Net profit for the period was a loss of ¥57,058,145.06, compared to a loss of ¥42,095,535.38 in the previous period, indicating a worsening of approximately 35.5%[23]. - Total comprehensive income amounted to -57,317,569.74 yuan, a decrease from -44,009,503.18 yuan in the previous period[24]. - Basic and diluted earnings per share were both -0.0618, compared to -0.0346 in the previous period[24]. Assets and Equity - Total assets at the end of the reporting period were ¥2,923,225,967.21, down 4.60% from the end of the previous year[5]. - The company's total assets decreased to ¥2,923,225,967.21 from ¥3,064,058,941.40, a decline of about 4.6%[20]. - The total equity attributable to shareholders was ¥1,509,784,666.51, down 3.23% from the previous year[5]. - The total equity attributable to shareholders decreased to ¥1,509,784,666.51 from ¥1,560,217,605.16, a decline of about 3.2%[20]. Cash Flow - The net cash flow from financing activities increased to ¥127,487,316.83, a rise of 343.06% compared to the previous year[11]. - Cash inflow from operating activities was 904,409,509.47 yuan, down from 970,049,205.98 yuan year-over-year[25]. - Net cash outflow from operating activities was -130,024,776.79 yuan, worsening from -42,245,806.92 yuan in the previous period[26]. - Cash inflow from investing activities totaled 575,659,254.93 yuan, an increase from 429,158,139.77 yuan year-over-year[26]. - Net cash flow from investing activities was 55,326,776.46 yuan, up from 11,028,477.51 yuan in the previous period[26]. - Cash inflow from financing activities was 574,239,442.05 yuan, compared to 405,010,335.29 yuan in the previous period[26]. - Net cash flow from financing activities improved to 127,487,316.83 yuan from -52,451,612.20 yuan year-over-year[26]. - The ending cash and cash equivalents balance was 333,581,940.22 yuan, compared to 312,832,810.91 yuan at the end of the previous period[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 65,036[13]. - The largest shareholder, Liao Dinghai, holds 18.85% of shares, totaling 140,281,830 shares[13]. - The second-largest shareholder, Liao Wen, holds 5.83% of shares, totaling 43,349,696 shares[13]. - The company has no changes in the number of restricted shares for major shareholders during the reporting period[15]. - The total number of restricted shares held by Liao Dinghai remains at 105,211,372 shares[15]. - The total number of restricted shares held by Liao Wen remains at 32,512,272 shares[16]. Investment and Expenses - The company reported an investment income of ¥27,838,683.04, an increase of 227.16% year-on-year[10]. - Research and development expenses were ¥91,693,380.67, slightly down from ¥96,844,485.27, a decrease of about 5.3%[23]. - The company reported an investment income of ¥27,838,683.04, significantly up from ¥8,509,118.17, an increase of approximately 227.5%[23]. Other Information - The company's cash and cash equivalents at the end of the period amount to ¥358,001,665.59, an increase from ¥337,233,360.77 at the beginning of the period[18]. - Accounts receivable decreased to ¥810,210,561.05 from ¥939,850,510.64 at the beginning of the period[18]. - The company has no new strategies or significant market expansions reported in the conference call[17]. - There are no new products or technologies mentioned in the financial report[17]. - The third quarter financial report was not audited[28].

Financial Performance - The company's operating revenue for the third quarter was ¥824,592,955.24, a decrease of 1.03% compared to the same period last year[4]. - The total profit for the third quarter was ¥73,844,121.34, with a net profit attributable to shareholders of ¥46,262,982.89[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥26,445,524.46, indicating a significant loss compared to the previous year[4]. - The basic earnings per share for the third quarter was ¥0.045, an increase from ¥0.03 year-to-date[5]. - The weighted average return on equity increased by 1.39 percentage points to 1.39% for the third quarter[5]. - Net profit for the first three quarters of 2025 was CNY 28,434,757.36, a significant recovery from a net loss of CNY 74,900,634.93 in the same period of 2024[24]. - The basic earnings per share for the first three quarters of 2025 was CNY 0.03, recovering from a loss of CNY -0.05 in the same period of 2024[24]. Assets and Liabilities - Total assets at the end of the reporting period were ¥6,021,377,069.35, reflecting a 0.40% increase from the end of the previous year[5]. - The equity attributable to shareholders increased by 6.66% to ¥3,491,347,384.88 compared to the previous year[5]. - The company's total current assets as of September 30, 2025, amount to ¥2,548,187,097.81, a decrease from ¥2,647,304,986.90 as of December 31, 2024[18]. - Total non-current assets increased to ¥3,473,189,971.54 from ¥3,350,182,579.12[19]. - Total current liabilities decreased to ¥1,463,834,598.86 from ¥1,621,759,478.57[19]. - The total liabilities decreased from CNY 2,424,094,756.41 in the previous year to CNY 2,234,560,865.22, a reduction of approximately 7.8%[20]. - The total equity attributable to shareholders increased to CNY 3,491,347,384.88 from CNY 3,273,462,542.83, marking a growth of about 6.7%[20]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥37,472,206.24, indicating an increase due to higher cash receipts from sales[5]. - The company's operating cash flow for the first three quarters of 2025 was CNY 37,472,206.24, compared to a negative cash flow of CNY -204,698,736.00 in 2024, indicating improved cash generation[26]. - The net cash flow from investing activities was -$6.47 million, an improvement from -$36.38 million in the previous period[27]. - Cash inflow from financing activities totaled $160.24 million, compared to $250.83 million in the previous period[27]. - The net cash flow from financing activities was -$138.20 million, worsening from -$84.43 million year-over-year[27]. Government Subsidies and Non-Recurring Items - Non-recurring gains and losses for the period totaled ¥72,708,507.35, with significant contributions from government subsidies and fair value changes of financial assets[9]. - The company reported a government subsidy of ¥4,089,155.25, which is expected to have a lasting impact on its financial performance[8]. - The company reported a significant increase in other comprehensive income, totaling CNY 153,559,021.36 in 2025, compared to a loss of CNY -57,867,987.08 in 2024[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 211,691[14]. - Zhejiang Wangxin Group Co., Ltd. holds 71,920,000 shares, accounting for 7.00% of total shares, with 54,450,000 shares pledged[14]. Research and Development - Research and development expenses decreased to CNY 130,232,305.00 in 2025 from CNY 166,956,651.15 in 2024, reflecting a reduction of approximately 22%[23]. Accounting Standards - The company did not apply new accounting standards starting from 2025[28].

江苏金迪克生物技术股份有限公司 2025 年第三季度报告 证券代码：688670 证券简称：金迪克 江苏金迪克生物技术股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是√否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 江苏金迪克生物技术股份有限公司 2025 年第三季度报告 注："本报告期"指本季度初至本季度末 3 个月期间，下同。 （二） 非经常性损益项目和金额 √适用 □不适用 2 / 12 单位:元 币种:人民币 非经常性损益项目 本期金额 年初至报告 期末金额 说明 非流动性资产处置损益，包括已计提资产减值准备的冲销 部分 -618.68 -758 ...

Financial Performance - Revenue for Q3 2025 was ¥238,183,243.37, a decrease of 13.54% compared to the same period last year[4] - Net profit attributable to shareholders was -¥2,996,125.44, representing a decline of 129.43% year-on-year[4] - Basic earnings per share were -¥0.0050, down 128.90% from the previous year[4] - Operating income decreased by 23.17% year-to-date, totaling ¥565,729,025.09[4] - Total operating revenue for the current period was ¥565,729,025.09, a decrease of 23.2% compared to ¥736,329,174.63 in the previous period[32] - The net profit for the current period was a loss of ¥12,649,367.30, compared to a net profit of ¥31,628,003.32 in the previous period[33] - The operating profit for the current period was a loss of ¥2,429,321.75, compared to an operating profit of ¥37,025,228.28 in the previous period[33] Cash Flow - The cash flow from operating activities for the year-to-date was ¥6,250,871.30, an increase of 108.28%[4] - Cash received from operating activities decreased by 34.99% to ¥427.30 million due to a reduction in interest income[11] - Cash recovered from investments rose by 34.70% to ¥77,363.72 million, attributed to an increase in redeemed bank wealth management products[11] - Cash received from investment income increased by 35.31% to ¥157.35 million, driven by higher returns from bank wealth management[11] - Cash paid for the acquisition of fixed assets and other long-term assets surged by 437.62% to ¥410.17 million, reflecting increased asset purchases[11] - Cash received from subsidiaries was zero, a decrease of 100.00% compared to ¥646.70 million in the previous year, due to net cash adjustments after subsidiary mergers[11] - Cash received from investment decreased by 61.23% to ¥227.37 million, due to reduced capital contributions from minority shareholders[11] - Cash paid for financing activities dropped by 90.06% to ¥404.45 million, mainly due to a decrease in equity repurchase payments[11] - Cash inflow from operating activities was ¥879,332,164.35, slightly up from ¥867,472,918.66 in the previous period[35] - The net cash flow from operating activities was $6,250,871.30, a significant improvement compared to a net outflow of $75,494,922.06 in the previous period[36] - The net cash flow from financing activities was $12,844,633.06, recovering from a net outflow of $74,934,648.07 in the prior period[36] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,076,897,498.09, a decrease of 2.13% from the end of the previous year[4] - The total liabilities decreased to ¥876,893,036.12 from ¥909,054,837.62, reflecting a reduction of 3.5%[30] - The total equity decreased to ¥2,200,004,461.97 from ¥2,234,667,297.86, a decline of 1.6%[30] Investments and R&D - The company increased its investment in new product and technology development, with development expenditures rising by 58.44% to ¥4,793.51[8] - R&D expenses exceeded CNY 100 million, accounting for 17.76% of operating revenue, as the company increased investments in AI and 5G technologies[19] - The company reported a significant increase in credit impairment losses, amounting to ¥1,166.49, due to enhanced collection efforts[9] - The company reported a significant increase in credit impairment losses of ¥11,664,922.14 compared to a loss of -¥11,288,897.91 in the previous period[33] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,954[13] - The largest shareholder, Lin Jing, holds 9.09% of shares, totaling 53,998,102 shares[13] Strategic Initiatives - The company’s subsidiaries are undergoing strategic transformations, focusing on emerging markets, which has temporarily impacted overall revenue due to a shift from traditional business[21] - The company has made significant progress in the rail transportation sector with the development of a new generation mobile communication system based on 5G technology, enhancing operational safety and efficiency[22] - The company has secured important commercial partnerships in the civil aviation sector, validating its capabilities in low-altitude economy and civil aviation development[23] - The order reserve is solid, with a notable increase in orders related to "AI + Rail," providing strong momentum for future performance recovery[24] - The company is actively expanding into international markets, successfully entering South Africa with a major project contract exceeding CNY 40 million[26] - The management is focused on long-term value growth, aiming to transition from a traditional solution provider to an "AI-driven" comprehensive solution provider[27] Accounting and Audit - The company did not undergo an audit for the third quarter financial report[37] - The company plans to implement new accounting standards starting in 2025[37]

Financial Performance - The company's operating revenue for the third quarter reached ¥1,921,977,746, an increase of 11.57% compared to the same period last year[4] - The total profit for the third quarter was a loss of ¥65,746,240, representing a decrease of 121.63% year-on-year[4] - The net profit attributable to shareholders for the third quarter was a loss of ¥74,019,429, down 124.32% from the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for the third quarter was a loss of ¥93,623,007, a decrease of 131.69% year-on-year[4] - The basic earnings per share for the third quarter was -¥0.15, a decrease of 125.00% compared to the same period last year[5] - The diluted earnings per share for the third quarter was also -¥0.15, reflecting a decrease of 125.86% year-on-year[5] - Net profit for the first three quarters of 2025 was CNY 112,555,677.35, a decrease of 57.7% compared to CNY 265,666,663.73 in the same period of 2024[23] - The company reported total comprehensive income attributable to the parent company of CNY 119,992,814.26 for the current period, down from CNY 259,474,837.16 in the previous period, reflecting a decrease of approximately 53.8%[24] - The basic and diluted earnings per share for the current period were both CNY 0.21, compared to CNY 0.51 in the previous period, marking a decline of about 58.8%[24] Cash Flow and Assets - The cash flow from operating activities for the year-to-date period was ¥970,242,270, an increase of 65.89% compared to the previous year[5] - As of September 30, 2025, cash and cash equivalents amount to 616,319,819.80 RMB, an increase from 576,863,694.94 RMB at the end of 2024[17] - The company's cash and cash equivalents at the end of the third quarter of 2025 stood at CNY 368,604,190.57, a decrease from CNY 401,535,441.55 at the beginning of the period[29] - In the first three quarters of 2025, the company generated cash inflows from operating activities amounting to CNY 6,258,199,257.46, a significant increase from CNY 3,869,696,445.06 in the same period of 2024, representing a growth of approximately 61.5%[26] - The net cash flow from operating activities for the first three quarters of 2025 was CNY 970,242,269.62, compared to CNY 584,865,177.09 in 2024, indicating an increase of about 65.9%[27] - Cash inflows from other operating activities amounted to CNY 579,602,239.87 in the first three quarters of 2025, compared to CNY 147,662,821.22 in 2024, indicating a substantial increase of about 292.5%[26] Shareholder Information - The total number of common shareholders at the end of the reporting period is 44,712[12] - Sichuan Juxing Enterprise Group Co., Ltd. holds 29.86% of shares, with 152,289,646 shares pledged[12] - Sichuan Hebang Investment Group Co., Ltd. owns 14.34% of shares, totaling 73,148,802 shares, also pledged[12] - The company completed a share buyback of 4,773,900 shares, accounting for 0.94% of total share capital, with a total expenditure of 99,988,226.04 RMB[14] - The company plans to increase its shareholding by at least 50 million RMB within 12 months, with a maximum holding of 30% of total share capital[15] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥9,704,576,904, an increase of 10.73% from the end of the previous year[5] - The company's total assets increased to CNY 9,704,576,903.50, up from CNY 8,764,113,124.65 year-over-year[20] - Total liabilities rose to CNY 6,465,332,433.32, compared to CNY 5,425,519,656.18 in the previous year, reflecting an increase of 19.2%[19] - The company’s total equity decreased to CNY 3,239,244,470.18 from CNY 3,338,593,468.47, reflecting a decline of 3% year-over-year[20] Investments and Expenses - Research and development expenses for the first three quarters of 2025 were CNY 36,370,422.23, an increase of 21.8% from CNY 29,902,608.07 in the same period of 2024[22] - The company reported a significant increase in inventory, which reached CNY 2,774,855,169.43, compared to CNY 2,092,577,839.97 in the previous year, marking a growth of 32.6%[20] - Long-term equity investments increased to CNY 10,811,710.11, up from CNY 9,770,535.26, indicating a growth of 10.6%[20] Financing Activities - Cash outflows from investing activities in the first three quarters of 2025 totaled CNY 916,503,614.98, compared to CNY 778,956,744.28 in 2024, representing an increase of approximately 17.7%[27] - The net cash flow from financing activities for the first three quarters of 2025 was negative CNY 432,798,685.12, compared to negative CNY 64,578,406.41 in 2024, indicating a worsening of cash flow by approximately 572.5%[29] - The company reported a total cash outflow of CNY 2,168,572,257.59 from financing activities in the first three quarters of 2025, compared to CNY 1,599,308,755.42 in 2024, representing an increase of approximately 35.7%[29] - The company received CNY 1,552,698,454.42 in cash from borrowings during the first three quarters of 2025, an increase from CNY 1,034,499,359.99 in the same period of 2024, reflecting a growth of approximately 50%[27]